Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gopal

Showing results (281-290 of 429) with videos related to

Pageof 43
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2019
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant WithdrawalAng Li, Qian Wu, Chris Davis, et al.
Leukemia & Lymphoma|December 24, 2013
Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacyAjay K Gopal, Nancy L Bartlett, Andres Forero-Torres, et al.
Microorganisms|August 28, 2025
The Effect of Apple and Pear Cultivars on In Vitro Fermentation with Human Faecal MicrobiotaAnna M E Hoogeveen, Christine A Butts, Caroline C Kim, et al.
Bone Marrow Transplantation|October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphomaR N Pham, T A Gooley, G E Keeney, et al.
American Journal of Hematology|June 17, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell LymphomaStephen D Smith, Suchitra Sundaram, Sharmila Giri, et al.
Bone Marrow Transplantation|May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myelomaD J Green, W I Bensinger, L A Holmberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for LymphomaSolomon A Graf, Jennifer E Vaughn, Thomas R Chauncey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantationRon Ram, Ted A Gooley, David G Maloney, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2018
Early loss of mitochondrial complex I and rewiring of glutathione metabolism in renal oncocytomaRaj K Gopal, Sarah E Calvo, Angela R Shih, et al.
Pageof 43

Showing results (281-290 of 429) with videos related to

Sort By:
Pageof 43
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2019
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant WithdrawalAng Li, Qian Wu, Chris Davis, et al.
Leukemia & Lymphoma|December 24, 2013
Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacyAjay K Gopal, Nancy L Bartlett, Andres Forero-Torres, et al.
Microorganisms|August 28, 2025
The Effect of Apple and Pear Cultivars on In Vitro Fermentation with Human Faecal MicrobiotaAnna M E Hoogeveen, Christine A Butts, Caroline C Kim, et al.
Bone Marrow Transplantation|October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphomaR N Pham, T A Gooley, G E Keeney, et al.
American Journal of Hematology|June 17, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell LymphomaStephen D Smith, Suchitra Sundaram, Sharmila Giri, et al.
Bone Marrow Transplantation|May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myelomaD J Green, W I Bensinger, L A Holmberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for LymphomaSolomon A Graf, Jennifer E Vaughn, Thomas R Chauncey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantationRon Ram, Ted A Gooley, David G Maloney, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2018
Early loss of mitochondrial complex I and rewiring of glutathione metabolism in renal oncocytomaRaj K Gopal, Sarah E Calvo, Angela R Shih, et al.
Pageof 43